International Journal of Cardiology
Volume 76, Issue 2 , Pages 157-163 , November 2000

Reasons for adherence with antihypertensive medication

  • Staffan Svensson

      Affiliations

    • Department of Clinical Pharmacology, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-31-342-2921; fax: +46-31-826-723
    • ,
  • Karin I Kjellgren

      Affiliations

    • Department of Medicine and Care, Linköping University Hospital, SE-581 85 Linköping, Sweden
    • ,
  • Johan Ahlner

      Affiliations

    • Department of Forensic Toxicology, Linköping University Hospital, SE-581 85 Linköping, Sweden
    • ,
  • Roger Säljö

      Affiliations

    • Department of Education, Göteborg University, Box 300, SE-405 30 Gothenburg, Sweden

Received 1 February 2000 ,Revised 14 July 2000 ,Accepted 4 September 2000.

References 

  1. WHO . World Health Statistics Annual. Geneva: World Health Organization; 1995;
  2. Guidelines Subcommittee . 1999 World Health Organization–International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151–183
  3. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–37
  4. Rosenstock I M. Enhancing patient compliance with health recommendations. J. Pediatr. Health Care. 1988;2:67–72
  5. Sackett D, Snow J. The magnitude of adherence and non-adherence. In:  Haynes R,  Taylor W,  Sackett D editor. Compliance in Health Care. Baltimore: John Hopkins University Press; 1979;p. 11–22
  6. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure . The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–2446[erratum, Arch Intern Med 1998;158:573]
  7. Kjellgren KI, Ahlner J, Säljö R. Taking antihypertensive medication-controlling or co-operating with patients?. Int J Cardiol. 1995;47:257–268
  8. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med. 1992;15:447–468
  9. Hays RD, DiMatteo M, Robin M. Key issues and suggestions for patient compliance assessment: Sources of information, focus of measures, and nature of response options. J Compliance Health Care. 1987;2:37–53
  10. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–386
  11. Lipkin M. Patient education and counseling in the context of modern patient–physician–family communication. Patient Educ Couns. 1996;27:5–11
  12. Kjellgren KI, Svensson S, Ahlner J, Säljö R. Hypertensive patients’ knowledge of high blood pressure. Scand. J Prim Health Care. 1997;15:188–192
  13. Kjellgren KI, Svensson S, Ahlner J, Säljö R. Antihypertensive medication in clinical encounters. Int J Cardiol. 1998;64:161–169
  14. Nyström F, Karlberg BE, Ohman KP. Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin–angiotensin system. J Hum Hypertens. 1997;11:301–306
  15. Gordis L. Conceptual and methodologic problems in measuring compliance. In:  Haynes R,  Taylor W,  Sackett D editor. Compliance in Health Care. Baltimore: John Hopkins University Press; 1979;p. 23–25
  16. Kjellgren KI, Svensson S, Ahlner J, Säljö R. Antihypertensive treatment and patient autonomy—the follow-up appointment as a resource for care. Patient Educ Couns. 2000;40:39–49

PII: S0167-5273(00)00374-0

International Journal of Cardiology
Volume 76, Issue 2 , Pages 157-163 , November 2000

Article Tools

* Image Usage & Resolution